G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Director – Portfolio Digital Capabilities & Innovation - HIV Treatment

Marketing Generalist & ManagementConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • A Bachelor's degree in Marketing or a related field and at least 12 years of relevant experience, or a Master's degree and at least 10 years of relevant experience, or a PhD and at least 8 years of relevant experience.
  • Experience leading complex, cross-functional initiatives within a highly matrixed organization.
  • Understanding of digital marketing, omnichannel engagement, personalization, NBA/NBE or related decisioning approaches, data-driven marketing, and emerging AI-enabled capabilities.
  • Ability to translate business strategy and customer needs into clear capability requirements and scalable solutions.
  • Experience evaluating pilots, establishing success measures, and using data and insights to guide prioritization, investment, and scale decisions.
  • Strategic and commercial judgment to evaluate emerging technology and innovation opportunities against customer and business needs.
  • Ability to influence senior stakeholders and lead across functions without direct authority.
  • Executive communication skills, including translating complex digital and technology topics into clear business implications and recommendations.
  • Ability to build productive partnerships across Marketing, Digital, Analytics, Sales, and external partners.

Responsibilities

  • Lead the portfolio business strategy for digital capabilities across HIV Treatment, translating portfolio strategy, brand needs, and customer opportunities into a prioritized capability roadmap.
  • Identify shared needs and opportunities across brands where digital capabilities can create greater impact, accelerate learning, or reduce duplication.
  • Lead portfolio prioritization of NBA/NBE, AI-enabled engagement, personalization, and other emerging digital capabilities, ensuring investments remain anchored in clearly defined business needs.
  • Partner with DSO and cross-functional stakeholders to assess emerging solutions and determine their relevance and applicability to HIV Treatment.
  • Develop business cases and decision-ready recommendations to guide capability investment, prioritization, and evolution.
  • Establish and lead a disciplined pilot-to-scale model that translates successful brand-led innovation into scalable, repeatable portfolio capabilities.
  • Partner with brand teams to define business needs, priority use cases, and success criteria while preserving brand ownership of differentiated strategy and execution.
  • Evaluate pilots and emerging solutions for broader portfolio applicability and determine where capabilities should be scaled, refined, or discontinued based on business value and strategic relevance.
  • Translate successful pilots into clear portfolio business requirements, partnering with DSO to enable broader deployment.
  • Capture and share learnings across brands to accelerate adoption of proven approaches and avoid recreating solutions brand by brand.
  • Lead the HIV Treatment portfolio business strategy for the continued evolution and integration of NBA/NBE and related precision-engagement capabilities.
  • Translate brand and portfolio priorities into actionable capability requirements and use cases, including opportunities to strengthen signals, triggers, decision logic, and personalization.
  • Partner with Brand Marketing, DSO, Analytics, Sales, and other stakeholders to advance precision-engagement capabilities and identify opportunities for continued optimization.
  • Drive integration and scalability as the HIV Treatment portfolio evolves, balancing differentiated brand needs with opportunities for greater consistency and efficiency.
  • Partner with Customer Engagement & Experience to ensure digital capabilities enable the intended customer journey while maintaining clear ownership of portfolio customer experience strategy within that role.
  • Drive adoption and realization of business value for prioritized digital capabilities, moving successful solutions from pilot to sustained use across the portfolio.
  • Establish business objectives, success criteria, and adoption measures in partnership with Brand Marketing, Analytics, DSO, and other stakeholders.
  • Use capability performance, adoption, and customer and business insights to inform continued investment, optimization, or discontinuation.
  • Translate performance and emerging opportunities into clear, decision-ready recommendations for HIV Treatment leadership.
  • Build connectivity and learning across brands and functions to strengthen digital acumen, accelerate reuse of successful approaches, and foster disciplined, business-driven innovation.
  • Create inclusion by modeling inclusion and embedding the value of diversity in how teams are managed.
  • Develop talent by understanding employees' skills, experience, aspirations, and potential, coaching them on performance and future potential, and ensuring they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding teams accountable, removing barriers, and connecting them to the broader ecosystem.

Desired Qualifications

  • Pharmaceutical, biotechnology, or other highly regulated industry experience.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs